Skip to main content

Advaxis, Inc. (ADXS)

NASDAQ: ADXS · Delayed Price · USD
0.360
0.006 (1.58%)
At close: Dec 8, 2021 4:00 PM
0.350
-0.010 (-2.778%)
Pre-market:Dec 9, 2021 5:35 AM EST
Market Cap52.43M
Revenue (ttm)3.24M
Net Income (ttm)-18.88M
Shares Out145.64M
EPS (ttm)-0.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,671,911
Open0.343
Previous Close0.354
Day's Range0.340 - 0.366
52-Week Range0.300 - 1.570
Beta2.22
Analystsn/a
Price Targetn/a
Earnings Daten/a

About ADXS

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunothe...

IndustryBiotechnology
Founded2002
CEOKenneth Berlin
Employees17
Stock ExchangeNASDAQ
Ticker SymbolADXS
Full Company Profile

Financial Performance

Financial Statements

News

Advaxis Issues Letter and Second Video Message to Stockholders Regarding Upcoming Special Meeting

Company releases video message highlighting the need for all proposals to pass in order to consummate the proposed Biosight transaction

2 weeks ago - GlobeNewsWire

Nasdaq Grants Advaxis, Inc. an Extension to December 20, 2021, to Complete Merger Transaction with Biosight, Ltd. and...

MONMOUTH JUNCTION, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (“Advaxis” or the “Company”), a clinical-stage biotechnology company focused on the development and commercializat...

2 weeks ago - GlobeNewsWire

Advaxis, Inc. Issues Letter to Stockholders

Advaxis urges stockholders to carefully evaluate the potential outcomes of the vote on the proposed merger with Biosight and vote FOR all proposals Advaxis urges stockholders to carefully evaluate the p...

2 weeks ago - GlobeNewsWire

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Advaxis Stockholders Vote “FOR” Propose...

Advaxis urges stockholders to vote “FOR” the merger with Biosight and all proposals Advaxis urges stockholders to vote “FOR” the merger with Biosight and all proposals

2 weeks ago - GlobeNewsWire

Biosight Encourages Advaxis Stockholders to Vote “FOR” Proposed Merger

Combined company, to be named Biosight Therapeutics, expected to be well-positioned to leverage its compelling oncology therapeutics pipeline, strong cash position, and accomplished management and Board...

3 weeks ago - GlobeNewsWire

3 Hot Penny Stocks That Retail Traders Are Watching Right Now

Why retail traders are watching these penny stocks right now The post 3 Hot Penny Stocks That Retail Traders Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | P...

Other symbols:PBTSPETV
4 weeks ago - PennyStocks

Advaxis Issues Letter and Video Message to Stockholders Regarding Upcoming Special Meeting

Company releases video message highlighting strategic rationale and benefits of proposed Biosight transaction for Advaxis stockholders

1 month ago - GlobeNewsWire

Leading Independent Proxy Advisory Firm ISS Recommends Advaxis Stockholders Vote “FOR” the Merger with Biosight

MONMOUTH JUNCTION, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products...

1 month ago - GlobeNewsWire

Top Penny Stocks to Buy From TikTok? 3 That Investors Are Watching

These penny stocks are popular on TikTok, are they on your watchlist? The post Top Penny Stocks to Buy From TikTok?

Other symbols:MMATPBTS
1 month ago - PennyStocks

6 of the Hottest Stocks to Pick Up for Less Than $1

These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals. The post 6 of the Hottest Stocks to Pick Up for Less Than $1 appeared first ...

Other symbols:SRGA
1 month ago - InvestorPlace

Best Penny Stocks to Buy Next Month? 3 You Need to Know About

Which penny stocks are on your November watchlist? The post Best Penny Stocks to Buy Next Month?

Other symbols:CSCWEBON
1 month ago - PennyStocks

Top Trending Penny Stocks to Watch Next Month

With so many trending penny stocks to buy, which small caps are you watching? The post Top Trending Penny Stocks to Watch Next Month appeared first on Penny Stocks to Buy, Picks, News and Information | ...

Other symbols:ABEVJOB
1 month ago - PennyStocks

3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now

These trending penny stocks could be worth adding to your October watchlist, here's why The post 3 Trending Penny Stocks For Your Small-Caps Watchlist Right Now appeared first on Penny Stocks to Buy, Pi...

Other symbols:IDEXNXE
1 month ago - PennyStocks

Top Biotech Penny Stocks to Watch With High Volume Right Now

Are these high volume biotech penny stocks worth adding to your watchlist right now? The post Top Biotech Penny Stocks to Watch With High Volume Right Now appeared first on Penny Stocks to Buy, Picks, N...

Other symbols:RSLSVYGR
2 months ago - PennyStocks

3 Tech Penny Stocks to Watch During the Market Crash

Can tech penny stocks perform well amidst today's stock market crash? The post 3 Tech Penny Stocks to Watch During the Market Crash appeared first on Penny Stocks to Buy, Picks, News and Information | P...

Other symbols:BESTSONM
2 months ago - PennyStocks

Hot Penny Stocks to Add to Your September Watchlist

Why investors are watching these 3 penny stocks right now The post Hot Penny Stocks to Add to Your September Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:CLSNTELL
2 months ago - PennyStocks

Advaxis Reports 3rd Quarter Ended July 31, 2021 Financial Results and Provides a Business Update

Entered definitive merger agreement with Biosight Ltd. to advance pipeline of clinical-stage oncology programs for solid tumors and hematological malignancies

2 months ago - GlobeNewsWire

3 Penny Stocks That Top Investors Are Watching Right Now

Why top investors are watching these penny stocks right now The post 3 Penny Stocks That Top Investors Are Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...

Other symbols:DNNSONM
3 months ago - PennyStocks

Trending Penny Stocks to Buy in September? Check These 3 Out

Are these penny stocks on your September small-caps watchlist? The post Trending Penny Stocks to Buy in September?

Other symbols:KXINSENS
3 months ago - PennyStocks

Nasdaq Grants Advaxis, Inc. an Extension to November 22, 2021, to Regain Compliance with the $1.00 Minimum Bid Price ...

MONMOUTH JUNCTION, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (“Advaxis” or the “Company”), a clinical-stage biotechnology company focused on the development and commercializat...

3 months ago - GlobeNewsWire

Popular Penny Stocks to Buy in 2021? Here's 4 You Should Know About

Why These 3 Penny Stocks Are Popular Among Traders Right Now The post Popular Penny Stocks to Buy in 2021? Here's 4 You Should Know About appeared first on Penny Stocks to Buy, Picks, News and Informati...

Other symbols:BBIGCETXTELL
4 months ago - PennyStocks

Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021

Reopening penny stocks are showing momentum right now; here's 6 to watch The post Hot Penny Stocks to Buy Now? 6 Reopening Stocks To Watch In July 2021 appeared first on Penny Stocks to Buy, Picks, News...

Other symbols:ABEVAHTGSATSONM
4 months ago - PennyStocks

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Advaxis, Inc. - ADXS

NEW YORK, July 16, 2021 /PRNewswire/-- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...

4 months ago - PRNewsWire

Advaxis Kick Starts Early-Stage Study For Prostate Cancer Immunotherapy

Advaxis Inc (NASDAQ: ADXS) has initiated a Phase 1 study evaluating ADXS-504 in patients with recurrent prostate cancer.  The study, being conducted at Columbia University Irving Medical Center, is the ...

4 months ago - Benzinga

Advaxis Announces Initiation of Phase 1 Clinical Trial of ADXS-504 for the Treatment of Early Prostate Cancer

Study in biochemically recurrent prostate cancer expands off-the-shelf ADXS-HOT program to second indication Study in biochemically recurrent prostate cancer expands off-the-shelf ADXS-HOT program to se...

4 months ago - GlobeNewsWire